“…Most of the existing radiogenomics studies have adopted an exploratory analysis approach to investigate the relationships between molecular dynamics and tumor characteristics reflected by specific radiographic phenotypes (radiophenotypes) [ 11 ]. For example, radiophenotypes, including tumor enhancement, nonenhancing tumor, necrosis, infiltrated edema, neo-angiogenesis, microstructural changes, and tumor location, have been associated with genomic profiles of the tumors to provide a better understanding of the underlying tumor biology [ 11 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 ]. Along these lines, a few radiogenomics studies have stratified high-grade glioma patients based on their risk, i.e., into groups of high, intermediate, and low-risk based on radiomic features that were predictive of overall or progression-free survival, and explored associations of these predictive radiomic features with gene expression profiles [ 54 ].…”